These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3857220)

  • 1. Effect of methotrexate on the immune response in children with acute lymphatic leukaemia.
    O'Meara A; Headon B; Reen DJ
    Immunopharmacology; 1985 Feb; 9(1):33-8. PubMed ID: 3857220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some immunological properties of lymphoid cells from patients with acute lymphatic leukaemia (ALL).
    Melief CJ; Schweitzer M; Zeylemaker WP; Verhagen EH; Eijsvoogel VP
    Clin Exp Immunol; 1973 Sep; 15(1):131-43. PubMed ID: 4520119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of sequential chemotherapy and radiotherapy on mitogen-induced lymphocyte transformation in patients with acute lymphoblastic leukemia.
    Humphrey GB; Parker DE
    Med Pediatr Oncol; 1976; 2(1):29-37. PubMed ID: 934028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte transformation in patients with acute lymphoblastic leukaemia.
    Jones LH; Hardisty RM; Wells DG; Kay HE
    Br Med J; 1971 Nov; 4(5783):329-30. PubMed ID: 5288226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of treatment in childhood leukaemia. II. Timing and the toxicity of combined 6-mercaptopurine and methotrexate maintenance therapy.
    MacLennan IC; Kay HE; Festenstein M; Smith PG
    Br J Haematol; 1976 Jun; 33(2):179-88. PubMed ID: 1063593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological follow-up of acute lymphoblastic leukaemia.
    Krepler P; Pawlowsky J; Kummer M; Brunner R; Eibl M; Pawlowsky G
    Haematologia (Budap); 1976; 10(1):11-22. PubMed ID: 1070465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of acute lymphoblastic leukaemia. Comparison of immunotherapy (B.C.G.), intermittent methotrexate, and no therapy after a five-month intensive cytotoxic regimen ((Concord trial). Preliminary report to the Medical Research Council by the Leukaemia Committee and the Working Party on Leukaemia in Childhood.
    Br Med J; 1971 Oct; 4(5781):189-94. PubMed ID: 4940157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term abnormalities in T and B lymphocyte function in children following treatment for acute lymphoblastic leukaemia.
    Layward L; Levinsky RJ; Butler M
    Br J Haematol; 1981 Oct; 49(2):251-8. PubMed ID: 6975114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological competence of patients in remission from acute leukaemia: apparently normal T cell function but defective pokeweed mitogen-driven immunoglobulin synthesis.
    Ashman LK; Drew PA; Toogood IR; Juttner CA
    Immunol Cell Biol; 1987 Apr; 65 ( Pt 2)():201-10. PubMed ID: 2956185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced lymphocyte response to PHA among leukemia patients taking oral lithium carbonate.
    Ridgway D; Wolff LJ; Neerhout RC
    Cancer Invest; 1986; 4(6):513-7. PubMed ID: 3103873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to phytohaemagglutinin and pokeweed mitogen in chronic lymphocytic leukaemia.
    Catovsky D; Tripp E; Hoffbrand AV
    Lancet; 1972 Apr; 1(7754):794-5. PubMed ID: 4111270
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunosuppression and serious infections in children with acute lymphoblastic leukaemia: a comparison of three chemotherapy regimes.
    Rapson NT; Cornbleet MA; Chessells JM; Bennett AJ; Hardisty RM
    Br J Haematol; 1980 May; 45(1):41-52. PubMed ID: 6929706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral methotrexate is as effective as intramuscular in maintenance therapy of acute lymphoblastic leukaemia.
    Chessells JM; Leiper AD; Tiedemann K; Hardisty RM; Richards S
    Arch Dis Child; 1987 Feb; 62(2):172-6. PubMed ID: 3469936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of T lymphocytes by protein A from Staphylococcus aureus in B-derived chronic lymphocytic leukaemia.
    Guglielmi P; Preud'Homme JL
    Clin Exp Immunol; 1980 Jul; 41(1):136-40. PubMed ID: 6969148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent chemotherapy and immunotherapy with BCG in remission maintenance of children with acute lymphocytic leukemia: effects upon immunological function.
    Ekert H; Jose DG; Wilson FC; Matthews RN; Lay H
    Int J Cancer; 1975 Jul; 16(1):103-12. PubMed ID: 1058172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy with oral BCG and serial immune evaluation in childhood lymphoblastic leukemia following three years of chemotherapy.
    Haghbin M; Cunningham-Rundles S; Thaler HT; Gupta S; Hecht S; Murphy ML; Oettgen HF
    Cancer; 1980 Dec; 46(12):2577-86. PubMed ID: 6969625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunity during pregnancy: lymphocyte subpopulations and mitogen responsiveness.
    Glassman AB; Bennett CE; Christopher JB; Self S
    Ann Clin Lab Sci; 1985; 15(5):357-62. PubMed ID: 2865928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phytohaemagglutinin stimulation of peripheral lymphocytes in children with acute lymphoblastic leukaemia during remission.
    Bakkeren JA; de Vaan GA; Schretlen ED
    Scand J Haematol; 1972; 9(1):36-42. PubMed ID: 4506604
    [No Abstract]   [Full Text] [Related]  

  • 19. Mitogenic stimulation of malignant B cells. Chronic lymphocytic leukaemia: relationship between stimulation and surface phenotype.
    Bloem AC; Bast EJ; Gmelig Meyling FH; DeGast GC; Ballieux RE
    Clin Exp Immunol; 1982 Nov; 50(2):355-9. PubMed ID: 6983937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy in previously treated acute lymphatic leukemia.
    Leventhal BG; LePourhiet A; Halterman RH; Henderson ES; Herberman RB
    Natl Cancer Inst Monogr; 1973 Dec; 39():177-87. PubMed ID: 4274495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.